Svas Biosana Receives €6M Equity Investment from IMI Fondi Chiusi

Svas Biosana, a Naples, Italy-based medical devices and infusion solutions company, has received a €6m equity investment from IMI Fondi Chiusi.

IMI Fondi Chiusi made the investment via Atlante Private Equity.

The company intends to use the proceeds from the investment to expand both organically and through acquisitions nationally and abroad.

Founded in 1970 and led by managing director Umberto Perillo, Svas Biosana operates in the field of planning, manufacturing and marketing of medical devices and pharmaceutical products. It employs 200 people and has a turnover of €47m.



Join the discussion